NEW YORK (GenomeWeb) – Roche Diagnostics said on Monday it has received CE mark for its Liat point-of-care platform and an assay for Clostridium difficile, along with three other assays which previously received CE marking. The Liat System complete test menu is now commercially available in countries accepting CE mark.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.